Medtronic Insulin Pump Blamed for NJ Death. Julie Baker-Dennis / April 21, 2015. Link copied (CN) - A New Jersey man who relied on a Medtronic device to administer the proper dose of insulin while he ...

Medtronic and the FDA left an insulin pump with a potentially deadly vulnerability on the market—until researchers who found the flaw showed how bad it could be.

The Medtronic pumps affected by the alert are: the MiniMed 508; MiniMed Paradigm models 511, 512/712, 712E, 515/715, 522/722, 522K/722K; plus Paradigm 523/723 and 523K/723K pumps with software ...

Medtronic has received 170 reports of hyperglycaemia and 11 reports of diabetic ketoacidosis from January 2023 to September 2024 in the US, which it says is potentially related to this issue.

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

Medtronic said on Thursday that it made two 510(k) submissions to the FDA: one for its MiniMed 780G insulin pump as an alternate controller enabled device, and another for its SmartGuard insulin ...

The M&A news came as Medtronic also released an earnings report summing up its fiscal year 2023, which ended April 28. Altogether, the company took in more than $31.2 billion for the year. Though ...

Sept 20 (Reuters) - The U.S. Food and Drug Administration on Tuesday warned that certain types of insulin pump systems manufactured by Medtronic (MDT.N), opens new tab were vulnerable to ...

Medtronic plc (NYSE: MDT), ... notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump’s built-in alerts and alarms for battery status and to ...

Products covered by the alert include the MiniMed Paradigm, MiniMed 600 series (640G, 670G) and MiniMed 700 series (770G, 780G) insulin pumps. However, insulin pump over- and under-delivery with ...